# Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma

> **NCT02775786** · NA · COMPLETED · sponsor: **Columbia University** · enrollment: 47 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **OTHER:** MRIs with and without intravenous contrast (up to 2)

## Key facts

- **NCT ID:** NCT02775786
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2021-02
- **Final completion:** 2021-02-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02775786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02775786, "Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02775786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*